Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
14°
Light Snow
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Edesa Biotech
Edesa Biotech to Present at ARDS Drug Development Summit
July 11, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
May 24, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech to Present at H.C. Wainwright Global Investment Conference
May 19, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Reports Fiscal 2nd Quarter 2022 Results
May 13, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected
April 28, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Appoints Strategy Expert to Board of Directors
March 29, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Announces Closing of $10.0 Million Registered Direct Offering
March 24, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 22, 2022
From
Edesa Biotech
Via
AccessWire
Tickers
EDSA
Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
February 17, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech Reports Fiscal 1st Quarter 2022 Results
February 14, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech to Join Ontario Bioscience Panel Discussion
January 26, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech Receives Canadian Approval to Test COVID-19 Drug as Rescue Therapy
January 13, 2022
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech Reports Fiscal Year 2021 Results
December 28, 2021
From
Edesa Biotech
Via
AccessWire
Exposures
COVID-19
Tickers
EDSA
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
December 01, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Extends COVID-19 Clinical Study to Poland
November 04, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Reports Favorable Mortality Reductions in COVID-19 Study
October 19, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
September 20, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
September 09, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule
August 26, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
August 13, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Extends Dermatitis Study to Canada
July 13, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment
June 23, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Reports Favorable Review of COVID-19 Study
June 18, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech to Attend BIO Digital 2021
June 08, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Reports Positive Interim Results in Dermatitis Trial
June 03, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech to Join Panel Discussion at Industry Event
May 28, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech Reports Fiscal 2nd Quarter 2021 Results
May 14, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Edesa Biotech to Host Key Opinion Leader Webinar on EB05 for the Treatment of Acute Respiratory Distress Syndrome
April 22, 2021
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Tickers
EDSA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
